Skip to main content
. 2018 Oct 18;22(12):6368–6379. doi: 10.1111/jcmm.13963

Figure 8.

Figure 8

Schematic representation of metformin/AMPK/ER signalling pathway and its potential crosstalk with bromocriptine/D2R pathway in prolactinoma treatment. Red arrow/line refers to regulatory relationship proposed in this study. Dashed line with question mark refers to potential AMPK‐independent pathway for BC/D2R to regulate ER expression